drugset / Trial / NCT01281553

A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease

NCT01281553 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy and tolerability of cisapride with placebo in infants and children with gastro-oesophageal reflux disease (GORD).

Timeline

Start
2003-09
Primary completion
—
Completion
2003-10

Outcome

Outcome not reported

Stopped: “Sponsor request”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisapride Small molecule 0.2 mg/kg Oral